247 related articles for article (PubMed ID: 22101256)
1. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
4. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A
Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077
[TBL] [Abstract][Full Text] [Related]
7. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
[TBL] [Abstract][Full Text] [Related]
8. [Aldehyde dehydrogenase 1 can be used as a new marker of cancer stem cells in laryngeal cancer cells in vitro].
Jin X; Zhao Y; Qian J; Tang J; Zhan XD
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):900-4. PubMed ID: 22340098
[TBL] [Abstract][Full Text] [Related]
9. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.
Rahadiani N; Ikeda J; Mamat S; Matsuzaki S; Ueda Y; Umehara R; Tian T; Wang Y; Enomoto T; Kimura T; Aozasa K; Morii E
Cancer Sci; 2011 Apr; 102(4):903-8. PubMed ID: 21231983
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
Resetkova E; Reis-Filho JS; Jain RK; Mehta R; Thorat MA; Nakshatri H; Badve S
Breast Cancer Res Treat; 2010 Aug; 123(1):97-108. PubMed ID: 19911270
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
Norwood MG; Bailey N; Nanji M; Gillies RS; Nicholson A; Ubhi S; Darnton JJ; Steyn RS; Womack C; Hughes A; Hemingway D; Harrison R; Waters R; Jankowski JA
Histopathology; 2010 Jul; 57(1):101-11. PubMed ID: 20572881
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1: a specific cancer stem cell marker for human colorectal carcinoma.
Zhou F; Mu YD; Liang J; Liu ZX; Zhou D; Ning WL; Li YZ; Ding D; Zhang JF
Mol Med Rep; 2015 May; 11(5):3894-9. PubMed ID: 25585687
[TBL] [Abstract][Full Text] [Related]
14. [Proliferation of cancer stem cells in colorectal adenocarcinoma].
Raskin GA; Orlova RV; Petrov SV; Protasova AÉ; Pozharisskiĭ KM
Vopr Onkol; 2014; 60(1):47-51. PubMed ID: 24772616
[TBL] [Abstract][Full Text] [Related]
15. [Advancement of studies on ALDH1 as a universal marker of stem cells].
Han M; Wu C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1183-6. PubMed ID: 21089696
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
17. Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Bednarz-Knoll N; Nastały P; Żaczek A; Stoupiec MG; Riethdorf S; Wikman H; Müller V; Skokowski J; Szade J; Sejda A; Wełnicka-Jaśkiewicz M; Pantel K
Oncotarget; 2015 Sep; 6(29):26789-803. PubMed ID: 26305673
[TBL] [Abstract][Full Text] [Related]
18. ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer.
Avoranta ST; Korkeila EA; Ristamäki RH; Syrjänen KJ; Carpén OM; Pyrhönen SO; Sundström JT
Hum Pathol; 2013 Jun; 44(6):966-74. PubMed ID: 23332924
[TBL] [Abstract][Full Text] [Related]
19. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer.
Magnusson C; Mezhybovska M; Lörinc E; Fernebro E; Nilbert M; Sjölander A
Eur J Cancer; 2010 Mar; 46(4):826-35. PubMed ID: 20064706
[TBL] [Abstract][Full Text] [Related]
20. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Kobayashi J; Sasaki T; Fujino J; Asanuma H; Tamura Y; Nakamori K; Hasegawa T; Hiratsuka H; Sato N
Pathol Int; 2012 Oct; 62(10):684-9. PubMed ID: 23005595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
